References
|
Camilio KA, et al. Complete Regression and Systemic Protective Immune Responses Obtained in B16 Melanomas after Treatment with LTX-315. Cancer Immunol Immunother 63.6(63):601-13, 2014. PubMed: 24676901
Miniati A, et al. Stimulated Human Melanocytes Express and Release Interleukin-8, Which Is Inhibited by Luteolin: Relevance to Early Vitiligo. Clin Exp Dermatol 39.1(39):54-7, 2014. PubMed: 23782102
Ding Z, et al. Loss of MiR-664 Expression Enhances Cutaneous Malignant Melanoma Proliferation by Upregulating PLP2. Medicine (Baltimore) 94.33(94):e1327, 2015. PubMed: 26287415
Lipiec E, et al. Monitoring UVR Induced Damage in Single Cells and Isolated Nuclei Using SR-FTIR Microspectroscopy and 3D Confocal Raman Imaging. Analyst 139.17(139):4200-9, 2014. PubMed: 24995477
Tian, F et al. miR-33a Is Downregulated in Melanoma Cells and Modulates Cell Proliferation by Targeting Pctaire1. Oncol Lett 4(11):2741-46, 2016. PubMed: 27073545
Wishrawana S, et al. Two novel atypical PKC inhibitors; ACPD and DNDA effectively mitigate cell proliferation and epithelial to mesenchymal transition of metastatic melanoma while inducing apoptosis. Intl J Oncol 51(5):1370-1382, 2017. DOI: 10.3892/ijo.2017.4131
Thanh DTH, et al. Toxicological and melanin synthesis effects of Polygonum multiflorum root extracts on zebrafish embryos and human melanocytes. Biomed Res Thera 3(9):808-818, 2016. Retrieved from: http://www.bmrat.org/index.php/BMRAT/article/view/4
Zhang W, et al. NS1/2-deficient respiratory syncytial virus and melanoma treatment. United States Patent Pat. No.: US 9,044,499 B1, 2015.
Stueven NA, et al. A Novel Stilbene-Like Compound That Inhibits Melanoma Growth by Regulating Melanocyte Differentiation and Proliferation. Toxicol Appl Pharmacol 337(337):30-38, 2017. PubMed: 29042215
|